Dupilumab in chronic actinic dermatitis: a retrospective case series-Reference-Cited by-同舟云学术

Dupilumab in chronic actinic dermatitis: a retrospective case series

Published:2024-04-24 Issue:2 Volume:191 Page:297-299
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:

Author:

O’Reilly Marese¹,Paolino Alexandra²,Pathmarajah Pirunthan²,Ferguson John²,Smith Catherine H²,Sarkany Robert²,Dawe Robert S¹²,Salam Amr²,Pink Andrew E²,Fassihi Hiva²,Ibbotson Sally¹

Affiliation:

1. Photobiology Unit, Ninewells Hospital , Dundee , UK

2. St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust , London , UK

Abstract

We report a retrospective case series from two UK photobiology units of 12 patients with concomitant atopic dermatitis (AD) and chronic actinic dermatitis (CAD) treated with dupilumab as a systemic monotherapy. While dupilumab is an effective therapy for moderate-to-severe AD, our results suggest that it may be less effective for the photosensitivity of CAD. In 11 of 12 patients with CAD, dupilumab was associated with improvement in dermatitis, but only half the patients noted improvement in photosensitivity.

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/bjd/advance-article-pdf/doi/10.1093/bjd/ljae180/57955640/ljae180.pdf

Reference8 articles.

1. The effectiveness and safety of dupilumab for the treatment of recalcitrant chronic actinic dermatitis: a case series;Chen;Clin Cosmet Investig Dermatol,2023

2. Dupilumab for the treatment of chronic actinic dermatitis;Patel;Photoderm Photoimmunol Photomed,2020

3. Successful treatment of chronic actinic dermatitis with dupilumab: a case report and review of the literature;Chen;Clin Cosmet Investig Dermatol,2021

4. A case report of therapeutically challenging chronic actinic dermatitis;Verma;SAGE Open Med Case Rep,2019

5. Dupilumab for the treatment of severe photodermatitis;Smith;JAAD Case Rep,2019